The combination of elafibranor and semaglutide drastically improves fibrosing steatohepatitis and distinctly modulates liver inflammatory signature
Year: 2020
Type: article
Source: Journal of Hepatology
Authors: Vanessa Legry, Philippe Poulain, Nicolas Stankovic Valentin, Peggy Parroche, Emeline Descamps, Carole Belanger, Dean Hum, Bart Staels, Stephen Harrison, Rohit Loomba, Arun Sanyal, Vlad Ratziu, Robert Walczak
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4230118985
